Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells

Objective(s): T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignant tumor. Administration of chemical compounds influencing apoptosis and T cell development has been discussed as promising novel therapeutic strategies. Valproic acid (VPA) as a recently emerged anti-neopl...

Full description

Bibliographic Details
Main Authors: Marie Saghaeian Jazi, Saeed Mohammadi, Yaghoub Yazdani, Sima Sedighi, Ali Memarian, Mehrdad Aghaei
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2016-07-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Online Access:http://ijbms.mums.ac.ir/article_7364_f26a238aaed8f3a1579682510a0d9c35.pdf
id doaj-38cc85bc183d4db4957e0375c4eba6ea
record_format Article
spelling doaj-38cc85bc183d4db4957e0375c4eba6ea2020-11-24T23:54:15ZengMashhad University of Medical SciencesIranian Journal of Basic Medical Sciences 2008-38662008-38742016-07-011977797867364Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cellsMarie Saghaeian Jazi0Saeed Mohammadi1Yaghoub Yazdani2Sima Sedighi3Ali Memarian4Mehrdad Aghaei5Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran|Department of Molecular Medicine, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, IranStudent Research Committee, Golestan University of Medical Sciences, Gorgan, Iran|Department of Molecular Medicine, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, IranInfectious Diseases Research Center and Laboratory Science Research Center, Golestan University of Medical Sciences, Gorgan, IranJoint, Bone, and Connective tissue Research Center (JBCRC), Golestan University of Medical Sciences, Gorgan, IranStem Cell Research Center, Golestan University of Medical Sciences, Gorgan, IranJoint, Bone, and Connective tissue Research Center (JBCRC), Golestan University of Medical Sciences, Gorgan, IranObjective(s): T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignant tumor. Administration of chemical compounds influencing apoptosis and T cell development has been discussed as promising novel therapeutic strategies. Valproic acid (VPA) as a recently emerged anti-neoplastic histone deacetylase (HDAC) inhibitor and pioglitazone (PGZ) as a high-affinity peroxisome proliferator-activated receptor-gamma (PPARγ) agonist have been shown to induce apoptosis and cell cycle arrest in different studies. Here, we aimed to investigate the underlying molecular mechanisms involved in anti-proliferative effects of these compounds on human Jurkat cells. Materials and Methods: Treated cells were evaluated for cell cycle progression and apoptosis using flowcytometry and MTT viability assay. Real-time RT-PCR was carried out to measure the alterations in key genes associated with cell death and cell cycle arrest. Results: Our findings illustrated that both VPA and PGZ can inhibit Jurkat E6.1 cells in vitro after   24 hr; however, PGZ 400 μM presents the most anti-proliferative effect. Interestingly, treated cells have been arrested in G2/M with deregulated cell division cycle 25A (Cdc25A) phosphatase and cyclin-dependent kinase inhibitor 1B (CDKN1B or p27) expression. Expression of cyclin D1 gene was inhibited when DNA synthesis entry was declined. Cell cycle deregulation in PGZ and VPA-exposed cells generated an increase in the proportion of aneuploid cell population, which has not reported before. Conclusion: These findings define that anti-proliferative effects of PGZ and VPA on Jurkat cell line are mediated by cell cycle deregulation. Thus, we suggest PGZ and VPA may relieve potential therapeutic application against apoptosis-resistant malignancies.http://ijbms.mums.ac.ir/article_7364_f26a238aaed8f3a1579682510a0d9c35.pdfPioglitazoneProliferationT-cell leukemiaValproic acid
collection DOAJ
language English
format Article
sources DOAJ
author Marie Saghaeian Jazi
Saeed Mohammadi
Yaghoub Yazdani
Sima Sedighi
Ali Memarian
Mehrdad Aghaei
spellingShingle Marie Saghaeian Jazi
Saeed Mohammadi
Yaghoub Yazdani
Sima Sedighi
Ali Memarian
Mehrdad Aghaei
Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells
Iranian Journal of Basic Medical Sciences
Pioglitazone
Proliferation
T-cell leukemia
Valproic acid
author_facet Marie Saghaeian Jazi
Saeed Mohammadi
Yaghoub Yazdani
Sima Sedighi
Ali Memarian
Mehrdad Aghaei
author_sort Marie Saghaeian Jazi
title Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells
title_short Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells
title_full Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells
title_fullStr Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells
title_full_unstemmed Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells
title_sort effects of valproic acid and pioglitazone on cell cycle progression and proliferation of t-cell acute lymphoblastic leukemia jurkat cells
publisher Mashhad University of Medical Sciences
series Iranian Journal of Basic Medical Sciences
issn 2008-3866
2008-3874
publishDate 2016-07-01
description Objective(s): T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignant tumor. Administration of chemical compounds influencing apoptosis and T cell development has been discussed as promising novel therapeutic strategies. Valproic acid (VPA) as a recently emerged anti-neoplastic histone deacetylase (HDAC) inhibitor and pioglitazone (PGZ) as a high-affinity peroxisome proliferator-activated receptor-gamma (PPARγ) agonist have been shown to induce apoptosis and cell cycle arrest in different studies. Here, we aimed to investigate the underlying molecular mechanisms involved in anti-proliferative effects of these compounds on human Jurkat cells. Materials and Methods: Treated cells were evaluated for cell cycle progression and apoptosis using flowcytometry and MTT viability assay. Real-time RT-PCR was carried out to measure the alterations in key genes associated with cell death and cell cycle arrest. Results: Our findings illustrated that both VPA and PGZ can inhibit Jurkat E6.1 cells in vitro after   24 hr; however, PGZ 400 μM presents the most anti-proliferative effect. Interestingly, treated cells have been arrested in G2/M with deregulated cell division cycle 25A (Cdc25A) phosphatase and cyclin-dependent kinase inhibitor 1B (CDKN1B or p27) expression. Expression of cyclin D1 gene was inhibited when DNA synthesis entry was declined. Cell cycle deregulation in PGZ and VPA-exposed cells generated an increase in the proportion of aneuploid cell population, which has not reported before. Conclusion: These findings define that anti-proliferative effects of PGZ and VPA on Jurkat cell line are mediated by cell cycle deregulation. Thus, we suggest PGZ and VPA may relieve potential therapeutic application against apoptosis-resistant malignancies.
topic Pioglitazone
Proliferation
T-cell leukemia
Valproic acid
url http://ijbms.mums.ac.ir/article_7364_f26a238aaed8f3a1579682510a0d9c35.pdf
work_keys_str_mv AT mariesaghaeianjazi effectsofvalproicacidandpioglitazoneoncellcycleprogressionandproliferationoftcellacutelymphoblasticleukemiajurkatcells
AT saeedmohammadi effectsofvalproicacidandpioglitazoneoncellcycleprogressionandproliferationoftcellacutelymphoblasticleukemiajurkatcells
AT yaghoubyazdani effectsofvalproicacidandpioglitazoneoncellcycleprogressionandproliferationoftcellacutelymphoblasticleukemiajurkatcells
AT simasedighi effectsofvalproicacidandpioglitazoneoncellcycleprogressionandproliferationoftcellacutelymphoblasticleukemiajurkatcells
AT alimemarian effectsofvalproicacidandpioglitazoneoncellcycleprogressionandproliferationoftcellacutelymphoblasticleukemiajurkatcells
AT mehrdadaghaei effectsofvalproicacidandpioglitazoneoncellcycleprogressionandproliferationoftcellacutelymphoblasticleukemiajurkatcells
_version_ 1725466505736355840